期刊文献+

食管鳞癌组织B7-H3和CD68表达及其临床意义 被引量:3

Expression and clinical significance of B7-H3 and CD68 in esophageal squamous cell carcinoma tissues
原文传递
导出
摘要 目的探讨食管鳞癌组织中共刺激分子B7-H3和肿瘤相关巨噬细胞(tumor-associated macrophage,TAM)标志CD68表达及其临床意义。方法采用免疫组织化学方法检测2006-01-02-2006-12-10河北医科大学第四医院70例食管鳞癌组织及对应癌旁组织中B7-H3和CD68的表达。分析食管鳞癌组织中B7-H3和CD68表达与临床病理特征之间的关系,以及两者之间的相关性。结果食管鳞癌组织中B7-H3阳性表达率为98.6%(69/70),明显高于对应癌旁组织的7.1%(5/70),差异有统计学意义,χ2=117.41,P<0.001;TAM标志CD68阳性表达率为91.4%(64/70),明显高于癌旁组织的18.6%(13/70),差异有统计学意义,χ2=75.07,P<0.001。B7-H3表达与患者肿瘤浸润深度显著相关,P=0.012;CD68表达与患者肿瘤浸润深度显著相关,P=0.039。食管鳞癌组织中B7-H3和CD68表达呈正相关,r=0.300,P<0.05。结论 B7-H3和TAM标志CD68在食管鳞癌组织中均呈过表达,且两者的过表达可能在食管鳞癌发生、发展中起重要作用。 OBJECTIVE To investigate the expression of the costimulatory molecule B7-H3 and CD68in ESCC tissues and its clinical significance.METHODS The expression of B7-H3 and CD68in 70 surgically resected specimens and corresponding adjacent tissues of ESCC were evaluated by immunohistochemistry.The relationship between B7-H3,CD68 expression and clinicopathological features was analyzed.RESULTS The expression of B7-H3 was higher in ESCC[98.6%(69/70)]than that in adjacent tissues[7.1%(5/70),χ^2=117.41,P〈0.001].The expression of CD68 was higher in ESCC [91.4%(64/70)]than that in adjacent tissues[18.6%(13/70),χ^2=75.07,P〈0.001].There was significant correlation between the expression of B7-H3 with tumor invasion depth in patients with ESCC(P〈0.05).Moreover,the expression of CD68 was correlated with tumor invasion depth(P〈0.05).Meanwhile,positive correlation was found among the expression of B7-H3 and CD68in ESCC(r=0.300,P〈0.05).CONCLUSION The expressions of B7-H3 and CD68are overexpressed in ESCC and may play an important role in the occurrence and development of ESCC.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第9期666-669,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然资金面上项目(81173611) 国家自然资金青年基金(81402228) 2013年省级重大医学科研课题(zd2013045)
关键词 食管鳞癌 免疫组织化学 B7-H3 CD68 esophageal squamous cell carcinoma immunohistochemistry B7-H3 CD68
  • 相关文献

参考文献4

二级参考文献21

  • 1Chang-Ping Wu,Jing-Ting Jiang,Min Tan,Yi-Bei Zhu,Mei Ji,Kuan-Feng Xu,Jie-Min Zhao,Guang-Bo Zhang,Xue-Guang Zhang.Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis[J].World Journal of Gastroenterology,2006,12(3):457-459. 被引量:39
  • 2Siveen KS,Kuttan G.Role of macrophages in tumour progression.Immunol Lett,2009;123(2):97~102.
  • 3Allavena P,Sica A,Solinas G,et al.The infl ammatory micro~environment in tumor progression:the role of tumor~associated macrophages.Crit Rev Oncol Hematol,2008;66(1):1~9.
  • 4Luo Y,Zhou H,Krueger J,et al.Targeting tumor~associated macrophages as a novel strategy against breast cancer.J Clin Invest,2006;116(8):2132~2141.
  • 5Calorini L,Bianchini F.Environmental control of invasiveness and metastatic dissemination of tumor cells:the role of tumor cell~host cell interactions.Cell Commun Signal,2010;8(1):24.
  • 6Coffelt SB,Hughes R,Lewis CE.Tumor~associated macrophages:effectors of angiogenesis and tumor progression.Biochim Biophys Acta,2009;1796(1):11~18.
  • 7Sica A,Allavena P,Mantovani A.Cancer related infl ammation:The macrophage connection.Cancer Lett,2008;267 (2):204~215.
  • 8Xiang R,Luo Y,Niethammer A G,et a1.Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.Immunol Rev,2008;222(1):117~128.
  • 9Morita H,Ishikawa Y,Akishima~Fukasawa Y,et al.Histopathological predictor for regional lymph node metastasis in gastric cancer.Virchows Arch,2009;454(2):143~151.
  • 10EI~Attar,Ragab MS,Sheta MI,et al.Hepatocyte growth factor in egyptian females with breast benign lumps and cancers.Asian Pac J Cancer Prev,2010;11(4):893~896.

共引文献26

同被引文献30

  • 1刘凌波,李蕾,肖娟,邹萍.急性单核细胞白血病M_(5a)和M_(5b)的免疫表型和临床表现比较分析(英文)[J].中国实验血液学杂志,2006,14(6):1079-1082. 被引量:2
  • 2Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments[J]. Cancer Res, 2006, 66 (2): 605- 612.
  • 3Lanaya H, Natarajan A, Komposch K, et al. EGFR has a tumou~ promoting role in liver macrophages during hepatocellular carcinoma formation[J]. Nat Cell Biol, 2014, 16(10): 972-981, 971-977.
  • 4Mantovani A, Allavena P. The interaction of anticancer thera pies with tumor-associated macrophages[J].J Exp Med, 2015, 212(4) : 435-445.
  • 5Sun J, Mao Y, Zhang YQ, et al. Clinical significance of the in- duction of maerophage differentiation by the costimulatory mole- cule BT-H3 in human nomsmall cell lung cancer[J]. Oncol Lett, 2013, 6(5): 1253-1260.
  • 6Ding T, Xu J, Wang F, et al. High tumor-infiltrating macro- phage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection[J]. Hum Pathol, 2009, 40(3) : 381-389.
  • 7Zhang W, Zhu XD, Sun HC, et al. Depletion of tumor-associat- ed macrophages enhances the effect of sorafenib in metastatic liv- er cancer models by antimetastatic and antiangiogenic effects. Clin Cancer Res[J].2010, 16(13): 3420-3430.
  • 8Yan W, Liu X, Ma H, et al. Tim-3 fosters HCC development by enhancing TGF-beta-mediated alternative activation of macro- phages[J]. Gut, 2015, 64(10): 1593-1604.
  • 9Wan S, Zhao E, Kryczek I, et al. Tumor-associated macrophages pro- duce interleukin 6 and signal via STAT 3 to promote expansion of hu- man hepatocellular carcinoma stem cells[J]. Gastroenterology, 2014, 147(6) : 1393-1404.
  • 10Yeung OW, Lo CM, Ling CC, et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellu- lar carcinoma[J]. J Hepatol, 2015, 62(3): 607-616.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部